Quantus

AMOREPACIFIC Holdings

A002790 · KOSPI
₩25,500-0.39%
2026-08-03 close

AMOREPACIFIC Holdings — pricey right now, or cheap? And what signals are flashing today?

Open the exact grade & valuation bands with Pro →
Loading chart…
Close
AI Insight

Why these signals fired — only backtest-proven edge, told honestly

Why this signalSignal guide

Moving-average alignment
No

No active signal.

Explore this stock further
Review signal, financial and filing context in chat
Explore in chat →

Strong-buy signal — the real recordrecord · not a prediction

Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)

Last 30 sessions
648 picks
Next-day win rate
49.2%
Avg next-day
-0.17%
vs market
+0.72%p

Beat the market on 62.1% of picks (each pick vs its own day’s market average).

Recent publish days (next-day win rate)
07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%07-15 50%07-14 71.4%07-13 31.2%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.

Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.

Valuation Grades

Relative to 150 화장품,의류,완구 peers · not investment advice

Pro unlocks the composite grade, 5 factors and sector rank · ₩19,900/mo

Valuation in its own history

PER 8.9 · PBR 0.67 — own history (2000-01~) percentiles 90/100 · 91/100

PER90/100
PBR91/100

Higher indicates lower valuation relative to its history (based on earnings and book yields).

Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend per share chart1987: 19원19871988: 26원1989: 36원1990: 41원19901991: 29원1992: 32원1993: 32원1994: 32원1995: 32원19951996: 23원1997: 20원1998: 26원1999: 32원2000: 44원20002001: 56원2002: 85원2003: 108원2004: 135원2005: 141원20052006: 176원2007: 125원2008: 145원2009: 145원2010: 160원20102011: 175원2012: 200원2013: 224원2014: 249원2015: 324원20152016: 389원2017: 459원2018: 359원2019: 309원2020: 300원20202021: 230원2022: 450원2023: 205원2024: 245원2025: 330원330원2025
Annual dividend (per share · split-adjusted) · as of 2025
Consistency
A+
Growth
D
Yield
C
Safety
A-
Reference indicatorView observed cut rates

Paid 39 consecutive years · Raised 2 consecutive years · Yield 1.29% (based on 2025 payment of 330원) · 3-year growth -9.8%

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 3.37
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
3.37
Beneish M-Score
-2.29

No statistical flag

Sloan accrual
-1.56%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Why has this company moved this way?

Auditable observations with the original numeric evidence.

매출 성장 + 마진 확대 + FCF 양수

Positive

매출이 +5.9% 성장하면서 영업이익률이 2.8%에서 12.4%로 확대되었다. FCF도 양수를 유지하여 질적 성장이 확인된다.

Evidence

매출 YoY +5.9%영업이익률 2.8%→12.4%FCF 502,912

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Cash conversion cycleWarning

현금전환주기(CCC) 5기 연속 확대 — 운전자본 경색·현금 회수 지연 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업외손익 급변 (영업이익 대비 54% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-08-03

화장품,의류,완구

This stock is in 화장품,의류,완구: revenue rank 6 of 146, share 4.6%.

6 / 1464.6%revenue share

Who dominates this industry?

  1. 1효성티앤씨8.3%
  2. 2LG생활건강7.3%
  3. 3코웨이4.6%
  4. 4영원무역홀딩스4.6%
  5. 5미스토홀딩스4.6%
  6. 6아모레퍼시픽홀딩스4.6%

Concentration

DistributedCR3 20.3%
HHI 318146 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedDivergent lenses

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
1.85
Direction
확대
Level
좁음
Years
8

Value lens

P90/P10
8.6
Median P/B
0.81
Level
넓음
n
140

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
12.4%
Interest coverage
18.2x
Return on equity (ROE)
7.6%

Operating margin −5pp

Tolerable
Interest coverageBase 18.2x adverse case 10.9x
Return on equity (ROE)Base 7.6% adverse case 8.6%

Revenue −15%

Tolerable
Interest coverageBase 18.2x adverse case 15.5x
Return on equity (ROE)Base 7.6% adverse case 12.6%

Interest rate +2pp

Tolerable
Interest coverageBase 18.2x adverse case 4x
Return on equity (ROE)Base 7.6% adverse case 11.9%

Interest coverage limit

Current margin 11.7pp

Interest coverage limit at an operating margin of 0.7%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-18

Suppliers disclosed by the company in its 2026-03-18 annual report.

Purchase amount

KRW 100m
  1. 오타종패키징퍼시픽
    KRW 20.6T
  2. 장업시스템
    KRW 20.6T
  3. BHD
    KRW 10.7T
  4. Ecogreen
    KRW 10.7T
  5. OLEO
    KRW 10.7T
  6. PALM
    KRW 10.7T
  7. SDNPrice comovement r=0.10 (1 year)
    KRW 10.7T
  8. 욱성물산
    KRW 10T
  9. 현대바이오랜드Price comovement r=0.47 (1 year)
    KRW 10T
  10. 태진화학
    KRW 8.4T

+11 more with disclosed amounts — included in coverage

Suppliers without disclosed amount

아모레퍼시픽의코스알엑스오설록농장에GLYCERINESyntheticEthylAlcoholJAUMBALANCINGCOMPLEXHairBeauty+29 more

Financials at a glance

AMOREPACIFIC Holdings's latest results and balance sheet. The bars track the last three periods.

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 서경배67.71%2026-04-03 · 증감 0.00%p
  • 국민연금공단7.25%2026-04-01 · 증감 +1.18%p

Connections

AI-extracted related companies · for reference

Customers
SephoraOlive YoungAmazonAlibaba
🔗 See in the full market map →

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ 37억 · 1w net inflow ≈ -0억(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

Recent filings

AMOREPACIFIC Holdings's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

Like these rules? Run them automatically.

Quantus turns rules like these into backtests and automated trading — same team, free to start.

Quantus Signal · live data · not investment advice · Privacy Policy